Compara los precios de RimWorld - Biotech (DLC) en tiendas de claves de confianza y encuentra la mejor oferta. Desarrollado por Ludeon Studios. Publicado por Ludeon Studios. Lanzado el 17/10/2018. Disponible en PC. Géneros: Indie, Simulation, Strategy. Puntuación Metacritic: 87/100.

RimWorld's Biotech DLC adds mechanoids, xenohumans, and child colonists to an already sprawling colony sim. It's the expansion that makes the base game feel incomplete without it.

RimWorld is a colony survival sim where a procedural AI storyteller (Randy Random, Cassandra Classic, or Phoebe Chillax) scripts disasters, relationships, and windfalls to keep your settlement perpetually on the edge. Biotech is one of its major expansions, and it rewires a surprising number of the game's core systems rather than just bolting new content onto the side. If you have played the base game and wondered whether the DLC is worth the extra spend, the short answer is that Biotech changes how you think about long-term colony planning in a fundamental way. The headline additions are three interlocking systems. First, mechanoid control: you can now research, build, and command a workforce of combat and labor mechs, each with upkeep costs measured in wastepacks that your colony has to manage or dump on someone else's lawn. The logistics chain this creates is genuinely interesting from a resource-flow perspective. Second, xenohumans: you can now design or encounter colonists with custom gene stacks that grant traits like aggression suppression, deathless resurrection, or fire immunity, opening up dedicated bloodfarm or warrior-caste colony archetypes that did not exist before. Third, children and pregnancy, which adds a demographic layer and long-horizon planning that rewards players who think thirty in-game years ahead rather than just surviving the next raid. What works well is how tightly these three pillars interact. A mech-heavy colony needs a mech commander colonist with the right skills, and that commander might be a xenotype you bred specifically for the role two in-game decades ago. The depth of decision-making here is real, not illusory. AI behavior around the new xenotypes is competent: enemy factions field their own xenohumans with abilities you have to account for tactically, and the storyteller integrates all of this into its incident generation rather than treating it as bolted-on content. The mod ecosystem, already enormous for the base game, has wrapped around Biotech quickly, so custom xenotypes and mechanoid variants are plentiful on the Steam Workshop. The honest downsides: the tutorial does not adequately explain the wastepack pollution system, and new players who jump straight into a mech-heavy playthrough will spend a few hours confused about why their map is turning toxic. Children and pregnancy slow down early-game pacing in ways that can frustrate players who prefer high-tempo crisis management over generational storytelling. And if you are brand new to RimWorld, buying Biotech at the same time as the base game is technically fine, but you will spend your first twenty hours not touching most of what this DLC offers. The base game's systems alone take meaningful time to internalize. Biotech rewards the player who already knows why having three doctors is better than one. For returning players or anyone past their first full colony run, Biotech is where the game's late-game gets its second wind. The mechanoid endgame gives a concrete progression goal that the base game's somewhat open-ended structure occasionally lacks. Xenotype design is the closest RimWorld has come to a character-building system, and it clicks well with the relationship and psychology simulation the base game already does. If you are the kind of player who opens a second monitor to track colony statistics, Biotech hands you a third spreadsheet tab. Diego, Scout Team

RimWorld - Biotech (DLC)

RimWorld - Biotech (DLC)

Complemento / DLC de RimWorld — ver juego completo
17 oct 2018Ludeon Studios
GamerScout opina

RimWorld's Biotech DLC adds mechanoids, xenohumans, and child colonists to an already sprawling colony sim. It's the expansion that makes the base game feel incomplete without it.

PC
Steam Deck VerifiedProtonDB Platinum
Mejor precio disponible
€0.00
en N/A
Mínimo histórico: €16.96

Comparar precios(0 tiendas)

Cargando precios...

We may earn a commission when you buy games through links on this page — at no extra cost to you. It never affects our rankings or verdicts.

Historial de precios

Historical low
€16.965 Jun 2026
Keyshops
€15.60€16.51€17.41€18.325 Jun11 Jun17 Jun22 Jun28 Jun
Tracking prices since 5 Jun 2026
Create alert

Capturas y multimedia

Acerca de RimWorld - Biotech (DLC)

RimWorld is a colony survival sim where a procedural AI storyteller (Randy Random, Cassandra Classic, or Phoebe Chillax) scripts disasters, relationships, and windfalls to keep your settlement perpetually on the edge. Biotech is one of its major expansions, and it rewires a surprising number of the game's core systems rather than just bolting new content onto the side. If you have played the base game and wondered whether the DLC is worth the extra spend, the short answer is that Biotech changes how you think about long-term colony planning in a fundamental way. The headline additions are three interlocking systems. First, mechanoid control: you can now research, build, and command a workforce of combat and labor mechs, each with upkeep costs measured in wastepacks that your colony has to manage or dump on someone else's lawn. The logistics chain this creates is genuinely interesting from a resource-flow perspective. Second, xenohumans: you can now design or encounter colonists with custom gene stacks that grant traits like aggression suppression, deathless resurrection, or fire immunity, opening up dedicated bloodfarm or warrior-caste colony archetypes that did not exist before. Third, children and pregnancy, which adds a demographic layer and long-horizon planning that rewards players who think thirty in-game years ahead rather than just surviving the next raid. What works well is how tightly these three pillars interact. A mech-heavy colony needs a mech commander colonist with the right skills, and that commander might be a xenotype you bred specifically for the role two in-game decades ago. The depth of decision-making here is real, not illusory. AI behavior around the new xenotypes is competent: enemy factions field their own xenohumans with abilities you have to account for tactically, and the storyteller integrates all of this into its incident generation rather than treating it as bolted-on content. The mod ecosystem, already enormous for the base game, has wrapped around Biotech quickly, so custom xenotypes and mechanoid variants are plentiful on the Steam Workshop. The honest downsides: the tutorial does not adequately explain the wastepack pollution system, and new players who jump straight into a mech-heavy playthrough will spend a few hours confused about why their map is turning toxic. Children and pregnancy slow down early-game pacing in ways that can frustrate players who prefer high-tempo crisis management over generational storytelling. And if you are brand new to RimWorld, buying Biotech at the same time as the base game is technically fine, but you will spend your first twenty hours not touching most of what this DLC offers. The base game's systems alone take meaningful time to internalize. Biotech rewards the player who already knows why having three doctors is better than one. For returning players or anyone past their first full colony run, Biotech is where the game's late-game gets its second wind. The mechanoid endgame gives a concrete progression goal that the base game's somewhat open-ended structure occasionally lacks. Xenotype design is the closest RimWorld has come to a character-building system, and it clicks well with the relationship and psychology simulation the base game already does. If you are the kind of player who opens a second monitor to track colony statistics, Biotech hands you a third spreadsheet tab.

Diego
Diego · Scout Team

Strategy & simulation

Etiquetas

steamColony ManagementGene EditingMechanoid CombatGenerational GameplayPollution MechanicsXenotype BuilderLate-Game DepthMod Support

Requisitos del sistema

Mínimos

Processor
Core 2 Duo
Memory
4 GB RAM
Graphics
Intel HD Graphics 4000 or other shader model 4.0
Storage
1 GB available space

Sigue explorando

Community Discussion

Be the first to comment on RimWorld - Biotech (DLC).

Reseñas y valoraciones

Metacritic
87
Steam
98%(239,393)

Información del juego

Desarrolladora
Ludeon Studios
Distribuidora
Ludeon Studios
Fecha de lanzamiento
17 oct 2018

Alerta de precio

¡Recibe un aviso cuando el precio baje de tu objetivo!

Crear alerta

Más de Ludeon Studios

Compra mejor: guías útiles

Preguntas frecuentes sobre RimWorld - Biotech (DLC)

¿Cuánto cuesta RimWorld - Biotech (DLC)?

El precio de RimWorld - Biotech (DLC) cambia a menudo y varía según la tienda, la edición y la región. La tabla de precios en vivo de esta página compara las ofertas más baratas en stock de tiendas de claves de confianza como Eneba y Kinguin, para que siempre veas el precio más bajo actual antes de comprar.

¿Dónde puedo comprar RimWorld - Biotech (DLC) más barato?

Compara los precios de RimWorld - Biotech (DLC) en todas las tiendas verificadas en la tabla de precios de esta página. Listamos las ofertas de claves y tiendas más baratas en stock, actualizadas con frecuencia, para que siempre veas la mejor oferta actual antes de comprar.

¿En qué plataformas está disponible RimWorld - Biotech (DLC)?

RimWorld - Biotech (DLC) está disponible en PC.

¿Cuándo se lanzó RimWorld - Biotech (DLC)?

RimWorld - Biotech (DLC) se lanzó el 17 de octubre de 2018.

¿Quién desarrolló RimWorld - Biotech (DLC)?

RimWorld - Biotech (DLC) fue desarrollado por Ludeon Studios.

¿Merece la pena comprar RimWorld - Biotech (DLC)?

RimWorld - Biotech (DLC) tiene una puntuación Metacritic de 87/100, lo que lo convierte en uno de los títulos destacados de Indie. Mira las reseñas completas, las valoraciones y los tiempos de duración en esta página para decidir.